— Know what they know.
Not Investment Advice

SCYX NASDAQ

SCYNEXIS, Inc.
1W: +16.6% 1M: -1.9% 3M: +8.2% YTD: +701.9% 1Y: +533.4% 3Y: +142.7% 5Y: -8.2%
$5.12
-0.25 (-4.66%)
 
Weekly Expected Move ±11.7%
$4 $5 $5 $6 $6
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 53 · $32.2M mcap · 6M float · 3.97% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.8 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -120.7%  ·  5Y Avg: -1.3%
Cost Advantage
21
Intangibles
82
Switching Cost
12
Network Effect
14
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SCYX has No discernible competitive edge (35.8/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. Negative ROIC of -120.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 13Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SCYX receives an overall rating of C. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 C+ C
2026-08-11 C C+
2026-08-10 C+ C
2026-07-30 C C+
2026-06-03 C- C
2026-06-01 C C-
2026-05-11 C+ C
2026-04-30 C C+
2026-04-01 C+ C
2026-03-24 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 40 Grade D
Profitability
40
Balance Sheet
84
Earnings Quality
73
Growth
88
Value
41
Momentum
80
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SCYX scores highest in Growth (88/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-3.25
Distress Zone
Piotroski F-Score
5/9
✗ ✗ ✓ ✗ ✓ ✓ ✓ ✗ ✓
Beneish M-Score
-2.72
Unlikely Manipulator
Ohlson O-Score
-5.53
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
BB
Score: 42.4/100
Trend: Improving
Earnings Quality
—
OCF/NI: 1.30x
Accruals: 4.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SCYX scores -3.25, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SCYX scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SCYX's score of -2.72 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SCYX's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SCYX receives an estimated rating of BB (score: 42.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.78x
PEG
0.01x
P/S
1.68x
P/B
0.90x
P/FCF
-3.62x
P/OCF
—
EV/EBITDA
2.19x
EV/Revenue
-0.21x
EV/EBIT
0.39x
EV/FCF
0.30x
Earnings Yield
-21.27%
FCF Yield
-27.66%
Shareholder Yield
5.28%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SCYX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
-0.533
EBIT / Rev
×
Asset Turnover
0.283
Rev / Assets
×
Equity Multiplier
1.218
Assets / Equity
=
ROE
-18.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SCYX's ROE of -18.4% is driven by Asset Turnover (0.283), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$5.12
Median 1Y
$2.56
5th Pctile
$0.42
95th Pctile
$15.18
Ann. Volatility
109.8%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
David Angulo, M.D.
President and Chief Executive Officer
$626,041 $283,961 $1,540,181
Ivor Macleod Financial
ancial Officer
$467,480 $99,912 $859,162
Scott Sukenick Legal
Legal Officer
$459,958 $99,912 $833,015

CEO Pay Ratio

2:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,540,181
Avg Employee Cost (SGA/emp): $799,722
Employees: 18

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
18
-35.7% YoY
Revenue / Employee
$1,144,500
Rev: $20,601,000
Profit / Employee
$-478,278
NI: $-8,609,000
SGA / Employee
$799,722
Avg labor cost proxy
R&D / Employee
$1,237,778
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -2.0% -1.0% -1.0% -1.3% -2.8% -2.8% -20.2% 64.0% 1.3% 1.8% 4.6% -46.1% -48.4% -33.3% -43.5% -37.2% -53.3% -16.5% -53.4% -18.4% -18.38%
ROA -63.2% -29.6% -31.8% -37.9% -69.9% -60.5% -1.0% 30.6% 55.4% 62.0% 1.1% -26.9% -29.4% -19.4% -29.1% -23.2% -33.7% -11.5% -33.7% -15.1% -15.09%
ROIC 2.2% 2.5% 7.5% 2.7% 2.2% 3.1% 1.7% 2.8% 4.0% 5.3% 8.4% -14.1% -7.4% -2.4% -2.3% -13.9% -38.7% -41.9% 1.2% -1.2% -1.21%
ROCE -48.8% -31.1% -39.6% -40.7% -78.8% -88.2% -3.5% 37.5% 60.0% 65.2% 1.2% -40.1% -47.7% -30.5% -45.2% -38.7% -58.4% -15.8% -39.7% -14.8% -14.80%
Gross Margin 71.9% 72.0% 85.6% 89.1% 87.9% 87.1% 87.9% 99.7% 78.5% -1.5% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% — 1.0% 1.00%
Operating Margin -37.7% -37.3% -28.7% -16.4% -14.0% -14.8% -9.5% 88.6% -5.7% -4.0% -6.9% -12.6% -15.6% -8.2% -33.5% -7.0% -25.2% 56.4% — -33.1% -33.09%
Net Margin -1.2% -49.0% -7.9% -10.1% -19.0% -9.5% -30.0% 93.0% -99.8% -3.4% 29.9% -19.6% -4.3% -4.5% -21.0% -5.0% -25.7% 65.7% — 31.5% 31.48%
EBITDA Margin 79.8% -46.9% -13.0% -8.7% -18.0% -8.4% -28.6% 95.6% -58.9% -3.2% 83.5% -19.4% -4.5% -3.8% 13.2% 2.0% -55.7% 65.7% — 31.5% 31.48%
FCF Margin -3.7% -4.2% -39.3% -18.9% -15.5% -12.0% -11.6% 7.5% 33.2% 42.9% 56.3% -63.9% -2.1% -5.3% -10.4% -7.4% -11.5% -25.6% -29.1% -69.3% -69.26%
OCF Margin -3.6% -4.1% -38.8% -24.6% -19.8% -15.7% -15.0% 7.5% 33.2% 42.9% 53.5% -1.1% -2.5% -6.4% -10.4% -7.4% -11.5% -25.6% -29.1% -69.3% -69.26%
ROE 3Y Avg snapshot only -39.26%
ROE 5Y Avg snapshot only -35.41%
ROA 3Y Avg snapshot only -26.21%
ROIC Economic snapshot only -26.07%
Cash ROA snapshot only -17.75%
Cash ROIC snapshot only -89.97%
CROIC snapshot only -89.97%
NOPAT Margin snapshot only -92.91%
Pretax Margin snapshot only -53.27%
R&D / Revenue snapshot only 1.37%
SGA / Revenue snapshot only 81.05%
SBC / Revenue snapshot only 12.29%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -3.17 -5.15 -3.86 -1.66 -1.47 -0.81 -1.57 3.32 1.51 1.59 0.70 -2.74 -1.99 -2.16 -1.74 -1.72 -1.52 -0.40 -0.24 -4.70 -2.783
P/S Ratio 11.71 12.86 72.09 25.78 27.38 10.01 25.89 1.09 0.80 0.76 0.51 10.04 8.46 12.27 17.90 10.30 13.10 0.17 0.29 2.50 1.676
P/B Ratio 3.91 4.10 3.33 1.77 6.62 15.77 -4.79 1.58 1.19 1.46 0.96 1.61 1.24 0.83 0.93 0.75 1.05 0.07 0.14 0.72 0.905
P/FCF -3.18 -3.04 -1.83 -1.36 -1.76 -0.83 -2.23 14.49 2.42 1.78 0.90 -15.71 -4.06 -2.30 -1.71 -1.39 -1.14 -0.65 -0.99 -3.62 -3.616
P/OCF — — — — — — — 14.49 2.42 1.78 0.95 — — — — — — — — — —
EV/EBITDA -1.91 -3.33 -2.14 -0.21 -0.87 -0.43 -1.63 1.44 0.45 0.65 0.06 -1.20 -0.56 -0.15 -0.51 13.43 1.26 -0.86 7.84 2.19 2.193
EV/Revenue 7.14 8.24 45.82 3.30 15.94 5.12 24.87 0.56 0.26 0.34 0.04 4.09 2.28 0.78 3.40 -2.71 0.92 -0.76 -2.52 -0.21 -0.209
EV/EBIT -1.90 -3.28 -2.11 -0.21 -0.86 -0.42 -1.62 1.46 0.45 0.65 0.06 -1.19 -0.56 -0.14 -0.34 0.46 -0.11 1.85 2.09 0.39 0.392
EV/FCF -1.94 -1.95 -1.17 -0.17 -1.03 -0.43 -2.14 7.48 0.79 0.79 0.08 -6.40 -1.09 -0.15 -0.33 0.37 -0.08 2.96 8.68 0.30 0.302
Earnings Yield -31.5% -19.4% -25.9% -60.4% -68.1% -1.2% -63.7% 30.1% 66.1% 62.7% 1.4% -36.5% -50.3% -46.3% -57.6% -58.1% -65.8% -2.5% -4.2% -21.3% -21.27%
FCF Yield -31.4% -32.9% -54.5% -73.3% -56.7% -1.2% -44.8% 6.9% 41.3% 56.3% 1.1% -6.4% -24.6% -43.5% -58.4% -71.8% -87.4% -1.5% -1.0% -27.7% -27.66%
PEG Ratio snapshot only 0.008
Price/Tangible Book snapshot only 0.719
EV/Gross Profit snapshot only -0.209
Shareholder Yield snapshot only 5.28%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 7.86 8.03 7.87 7.85 7.26 4.49 1.31 9.01 7.66 6.26 3.72 3.75 3.13 3.00 5.83 5.20 5.75 7.04 3.94 9.65 9.654
Quick Ratio 7.81 8.00 7.78 7.81 7.21 4.44 1.29 8.37 6.88 6.26 3.72 3.75 3.13 3.00 5.83 5.20 5.75 7.04 3.94 9.65 9.654
Debt/Equity 1.14 1.06 1.23 1.07 2.82 15.03 -1.64 0.16 0.16 0.21 0.21 0.26 0.27 0.30 0.05 0.05 0.06 0.04 0.05 0.03 0.029
Net Debt/Equity -1.53 -1.48 -1.21 -1.54 -2.77 -7.70 — -0.77 -0.80 -0.81 -0.88 -0.95 -0.90 -0.78 -0.75 -0.95 -0.98 -0.39 -1.38 -0.78 -0.779
Debt/Assets 0.39 0.36 0.43 0.36 0.43 0.55 0.70 0.09 0.10 0.12 0.13 0.14 0.16 0.18 0.04 0.04 0.04 0.04 0.03 0.03 0.026
Debt/EBITDA -0.91 -1.34 -1.24 -1.01 -0.63 -0.79 -0.58 0.28 0.19 0.20 0.14 -0.47 -0.46 -0.82 -0.14 -3.64 1.06 0.12 -0.31 -1.06 -1.063
Net Debt/EBITDA 1.22 1.87 1.23 1.46 0.62 0.41 0.07 -1.35 -0.92 -0.80 -0.61 1.75 1.52 2.17 2.17 64.53 -16.64 -1.05 8.73 28.49 28.491
Interest Coverage -14.61 -8.33 -7.89 -8.28 -12.41 -9.10 -12.54 6.19 10.99 12.45 21.22 -13.83 -14.10 -7.95 -10.97 -10.64 -21.46 -17.39 — — —
Equity Multiplier 2.92 2.90 2.87 2.98 6.53 27.16 -2.35 1.66 1.61 1.76 1.60 1.78 1.69 1.65 1.34 1.36 1.40 1.20 1.88 1.12 1.120
Cash Ratio snapshot only 9.285
Cash to Debt snapshot only 27.806
FCF to Debt snapshot only -6.843
Defensive Interval snapshot only 472.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.17 0.12 0.02 0.02 0.04 0.05 0.06 0.93 1.04 1.30 1.49 0.07 0.07 0.03 0.03 0.04 0.04 0.28 0.28 0.28 0.283
Inventory Turnover 0.46 1.35 0.72 1.54 0.85 0.92 0.59 0.17 0.16 34.76 28.03 2.93 2.24 — — — — — — — —
Receivables Turnover 866.62 7.04 1.37 2.82 3.30 3.44 3.00 11.40 11.30 13.06 13.04 0.47 0.55 0.25 0.18 0.22 0.30 4.02 4.18 3.84 3.843
Payables Turnover 0.02 0.05 0.06 0.07 0.08 0.09 0.09 0.14 0.21 2.39 2.09 3.44 3.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
DSO 0 52 266 129 111 106 122 32 32 28 28 776 662 1443 2026 1653 1214 91 87 95 95.0 days
DIO 794 271 510 237 432 396 618 2102 2229 10 13 125 163 — — — — — — — —
DPO 16065 7304 6503 5230 4548 4006 3851 2575 1749 153 175 106 105 — — — — — — — —
Cash Conversion Cycle -15270 -6981 -5727 -4864 -4006 -3504 -3112 -441 512 -114 -134 794 720 — — — — — — — —
Fixed Asset Turnover snapshot only 12.177
Cash Velocity snapshot only 0.355
Capital Intensity snapshot only 3.902
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — -85.1% -74.1% -66.9% -61.3% 2.1% 42.4% 31.6% 26.5% 24.4% -92.9% -93.7% -97.3% -98.1% -66.3% -65.8% 4.5% 6.7% 4.9% 4.90%
Net Income -72.0% 40.4% 36.4% -8.5% -67.5% -91.1% -1.7% 1.9% 1.9% 2.1% 2.1% -1.8% -1.5% -1.3% -1.3% 44.9% 30.6% 59.6% 9.5% 47.6% 47.56%
EPS 17.0% 77.2% 49.1% 33.6% 2.1% -62.3% -88.5% 1.8% 1.9% 1.7% 2.1% -1.8% -1.5% -1.4% -1.3% 46.2% 32.4% -1.8% -6.0% -1.2% -1.21%
FCF 0.1% -12.9% -95.2% -50.8% -39.8% -10.0% 9.2% 1.2% 1.7% 2.0% 2.2% -1.6% -1.4% -1.3% -1.3% -2.9% -88.4% 73.6% 78.5% 44.8% 44.78%
EBITDA -62.4% 42.8% 27.7% -4.2% -62.9% -87.8% -1.2% 2.1% 2.0% 2.2% 2.3% -1.6% -1.4% -1.3% -1.2% 98.0% 1.1% 1.9% 62.8% -1.8% -1.79%
Op. Income -7.9% -18.9% -96.1% -81.1% -58.8% -41.0% 2.9% 1.7% 1.9% 1.8% 2.0% -1.8% -1.7% -1.5% -1.5% 29.6% 33.6% 56.7% 32.7% 38.2% 38.16%
OCF Growth snapshot only 44.78%
Asset Growth snapshot only 23.52%
Equity Growth snapshot only 50.52%
Debt Growth snapshot only -18.59%
Shares Change snapshot only -76.23%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 2.7% 2.7% 91.6% 1.3% 1.8% 2.5% 3.6% — — — 1.3% -7.1% -12.0% -34.2% 13.5% 1.4% -11.0% 59.4% 54.3% -47.9% -47.87%
Revenue 5Y 1.2% 1.2% 47.7% 64.9% 74.7% 81.8% 84.9% 2.5% 2.5% 2.5% 2.5% 1.1% 1.2% 98.7% 1.2% — — — 11.0% 9.8% 9.78%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 2.6% 2.7% 75.7% 1.2% 1.7% 2.3% 3.4% — — — 1.2% — — -33.7% 23.7% 8.3% -6.3% 66.5% 61.1% -47.8% -47.75%
Gross Profit 5Y — 1.2% 40.2% 58.6% 69.3% 77.1% 80.2% 2.5% 2.5% 2.4% 2.4% — — 98.7% 1.2% — — — 11.0% 9.8% 9.78%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 28.6% 31.1% 35.3% 48.9% 49.2% 15.4% 19.2% 50.7% 59.3% 7.8% 5.7% -3.8% -3.4% -8.9% -15.2% -23.5% -23.1% -12.4% 3.4% -21.5% -21.48%
Assets 5Y 12.5% 14.9% 14.5% 21.2% 17.7% 13.9% 1.4% 21.7% 23.5% 19.3% 21.3% 21.3% 24.0% 9.7% 10.3% 6.0% 6.8% -10.5% -5.0% -9.1% -9.15%
Equity 3Y 10.5% 9.7% 50.9% 63.5% 41.0% -36.9% — 1.4% 1.1% 47.5% 41.9% 23.2% 15.9% 10.1% 9.1% -0.7% 28.4% 1.5% — -10.4% -10.41%
Book Value 3Y -38.9% -38.3% -20.1% -18.7% -26.6% -57.9% — 43.4% 39.1% -10.7% 16.0% 0.7% -3.9% -0.8% -4.5% -5.2% 26.3% 3.5% — 44.8% 44.80%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.39 0.39 0.19 0.27 0.32 0.36 0.17 0.45 0.45 0.46 0.43 0.15 0.15 0.13 0.13 0.01 0.01 0.03 0.01 0.05 0.048
Earnings Stability 0.24 0.22 0.42 0.93 0.74 0.46 0.61 0.23 0.12 0.19 0.18 0.10 0.08 0.30 0.14 0.10 0.04 0.21 0.08 0.08 0.079
Margin Stability 0.00 0.99 0.89 0.91 0.93 0.94 0.89 0.91 0.93 0.93 0.89 0.00 0.00 0.94 0.89 0.00 0.00 0.93 0.93 0.00 0.000
Rev. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.84 0.85 0.97 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.81 0.810
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 3.21 2.50 3.08 2.45 -2.49 -17.82 — 1.70 3.66 11.03 — -0.29 1.24 8.87 — -0.38 -0.78 -0.44 -1.01 0.36 0.359
Gross Margin Trend — — -0.23 — — — -0.01 0.08 0.07 -0.04 0.06 -1.47 -1.64 0.12 0.12 0.78 0.86 0.06 0.06 0.78 0.779
FCF Margin Trend — — 362.88 — — — 9.56 11.15 9.93 8.57 26.03 8.77 5.51 0.47 -4.92 -7.12 -10.58 2.20 4.65 3.33 3.326
Sustainable Growth Rate — — — — — — — 64.0% 1.3% 1.8% 4.6% — — — — — — — — — —
Internal Growth Rate — — — — — — — 44.0% 1.2% 1.6% -14.4% — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.98 1.66 2.07 1.58 1.06 1.27 0.91 0.23 0.62 0.90 0.74 0.29 0.60 1.13 1.01 1.23 1.33 0.61 0.24 1.30 1.300
FCF/OCF 1.01 1.02 1.01 0.77 0.78 0.77 0.78 1.00 1.00 1.00 1.05 0.61 0.82 0.83 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 1.300
CapEx/Revenue 4.7% 8.9% 54.5% 5.7% 4.3% 3.6% 3.4% 0.0% 0.0% 0.0% 2.9% 41.5% 46.8% 1.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.01 0.20 0.34 0.22 0.04 0.16 -0.09 0.24 0.21 0.06 0.28 -0.19 -0.12 0.02 0.00 0.05 0.11 -0.04 -0.26 0.05 0.045
Sloan Accruals snapshot only -0.053
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — 0.0% 0.0% 0.0% 0.0% — — — — — — — — — —
FCF Payout Ratio — — — — — — — 0.0% 0.0% 0.0% 0.0% — — — — — — — — — —
Total Payout Ratio — — — — — — — 0.0% 0.0% 0.0% 0.0% — — — — — — — — — —
Div. Increase Streak 0 — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.3% 5.28%
Net Buyback Yield -63.7% -22.8% -31.4% -98.6% -65.7% -87.0% -29.5% -0.1% -0.0% -0.1% -0.2% -0.1% -0.1% -0.3% -0.3% -0.4% -0.4% -4.9% -4.1% -77.5% -77.47%
Total Shareholder Return -63.7% -22.8% -31.4% -98.6% -65.7% -87.0% -29.5% -0.1% -0.0% -0.1% -0.2% -0.1% -0.1% -0.3% -0.3% -0.4% -0.4% -4.9% -4.1% -77.5% -77.47%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.94 0.91 0.79 0.91 0.94 0.93 1.00 1.00 1.00 1.00 0.99 1.02 1.01 1.01 0.99 0.98 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.05 1.09 1.09 1.10 1.07 1.09 1.07 0.85 0.91 0.92 0.96 1.05 1.03 1.04 1.03 1.03 1.02 1.02 1.00 1.00 1.000
EBIT Margin -3.75 -2.51 -21.68 -15.59 -18.55 -12.16 -15.40 0.38 0.58 0.52 0.76 -3.43 -4.08 -5.42 -10.14 -5.92 -8.49 -0.41 -1.21 -0.53 -0.533
Asset Turnover 0.17 0.12 0.02 0.02 0.04 0.05 0.06 0.93 1.04 1.30 1.49 0.07 0.07 0.03 0.03 0.04 0.04 0.28 0.28 0.28 0.283
Equity Multiplier 3.11 3.47 3.26 3.30 4.05 4.67 20.18 2.10 2.39 2.84 4.27 1.71 1.64 1.71 1.49 1.61 1.58 1.43 1.58 1.22 1.218
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.67 $-1.18 $-1.01 $-1.12 $-1.63 $-1.92 $-1.91 $0.89 $1.51 $1.40 $2.09 $-0.73 $-0.75 $-0.56 $-0.55 $-0.39 $-0.51 $-1.58 $-3.85 $-0.87 $-0.87
Book Value/Share $1.36 $1.49 $1.17 $1.05 $0.36 $0.10 $-0.63 $1.86 $1.92 $1.52 $1.53 $1.25 $1.20 $1.45 $1.02 $0.89 $0.73 $9.07 $6.48 $5.66 $5.66
Tangible Book/Share $1.31 $1.45 $1.14 $1.03 $0.35 $0.09 $-0.63 $1.86 $1.92 $1.52 $1.53 $1.25 $1.20 $1.45 $1.02 $0.89 $0.73 $9.07 $6.48 $5.66 $5.66
Revenue/Share $0.45 $0.47 $0.05 $0.07 $0.09 $0.16 $0.12 $2.72 $2.84 $2.92 $2.89 $0.20 $0.18 $0.10 $0.05 $0.07 $0.06 $3.79 $3.19 $1.63 $1.63
FCF/Share $-1.66 $-2.01 $-2.13 $-1.36 $-1.36 $-1.88 $-1.35 $0.20 $0.94 $1.26 $1.63 $-0.13 $-0.37 $-0.53 $-0.56 $-0.48 $-0.67 $-0.97 $-0.93 $-1.13 $-1.13
OCF/Share $-1.64 $-1.97 $-2.10 $-1.77 $-1.74 $-2.44 $-1.73 $0.20 $0.94 $1.26 $1.55 $-0.21 $-0.45 $-0.63 $-0.56 $-0.48 $-0.67 $-0.97 $-0.93 $-1.13 $-1.13
Cash/Share $3.61 $3.76 $2.87 $2.74 $2.02 $2.25 $1.15 $1.72 $1.85 $1.55 $1.66 $1.51 $1.42 $1.56 $0.82 $0.90 $0.76 $3.91 $9.30 $4.57 $4.57
EBITDA/Share $-1.69 $-1.17 $-1.16 $-1.11 $-1.61 $-1.87 $-1.77 $1.05 $1.66 $1.54 $2.21 $-0.68 $-0.72 $-0.52 $-0.36 $-0.01 $0.04 $3.33 $-1.03 $-0.15 $-0.15
Debt/Share $1.54 $1.57 $1.44 $1.12 $1.02 $1.49 $1.03 $0.29 $0.31 $0.31 $0.31 $0.32 $0.33 $0.43 $0.05 $0.05 $0.05 $0.40 $0.32 $0.16 $0.16
Net Debt/Share $-2.07 $-2.19 $-1.42 $-1.62 $-1.00 $-0.76 $-0.12 $-1.43 $-1.54 $-1.24 $-1.35 $-1.19 $-1.09 $-1.13 $-0.77 $-0.85 $-0.72 $-3.51 $-8.98 $-4.41 $-4.41
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -3.248
Altman Z-Prime snapshot only -7.574
Piotroski F-Score 5 3 2 2 1 1 3 7 6 6 7 3 2 2 2 3 3 6 5 5 5
Beneish M-Score — — 18.54 — 25.25 -0.29 -2.40 85.65 6.11 1.97 5.14 51.78 -3.86 -4.14 -2.38 -2.48 -2.10 12.69 — -2.72 -2.722
Ohlson O-Score snapshot only -5.532
ROIC (Greenblatt) snapshot only -19.69%
Net-Net WC snapshot only $4.08
EVA snapshot only $-19331620.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB
Credit Score 26.61 26.16 27.11 26.50 25.02 22.27 20.00 66.13 71.30 65.61 72.86 30.43 30.28 30.06 31.52 31.51 29.47 31.11 41.43 42.37 42.372
Credit Grade snapshot only 12
Credit Trend snapshot only 10.860
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 32
Sector Credit Rank snapshot only 36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms